288 related articles for article (PubMed ID: 11894406)
1. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
Wanke R; Wolf E; Brem G; Hermanns W
Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
[TBL] [Abstract][Full Text] [Related]
2. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.
Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A
Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008
[TBL] [Abstract][Full Text] [Related]
5. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
[TBL] [Abstract][Full Text] [Related]
6. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
[TBL] [Abstract][Full Text] [Related]
7. Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene.
Yang CW; Striker LJ; Kopchick JJ; Chen WY; Pesce CM; Peten EP; Striker GE
Kidney Int Suppl; 1993 Jan; 39():S90-4. PubMed ID: 8468934
[TBL] [Abstract][Full Text] [Related]
8. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
9. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury.
Matsusaka T; Xin J; Niwa S; Kobayashi K; Akatsuka A; Hashizume H; Wang QC; Pastan I; Fogo AB; Ichikawa I
J Am Soc Nephrol; 2005 Apr; 16(4):1013-23. PubMed ID: 15758046
[TBL] [Abstract][Full Text] [Related]
10. Podocyte lesions in patients with obesity-related glomerulopathy.
Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
[TBL] [Abstract][Full Text] [Related]
11. Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone.
Pesce CM; Striker LJ; Peten E; Elliot SJ; Striker GE
Lab Invest; 1991 Nov; 65(5):601-5. PubMed ID: 1753707
[TBL] [Abstract][Full Text] [Related]
12. New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure.
Nakano Y; Hirano T; Uehara K; Nishibayashi S; Hattori K; Aihara M; Yamada Y
Pathol Int; 2008 Jun; 58(6):361-70. PubMed ID: 18477215
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.
Zuo Y; Matsusaka T; Zhong J; Ma J; Ma LJ; Hanna Z; Jolicoeur P; Fogo AB; Ichikawa I
J Am Soc Nephrol; 2006 Oct; 17(10):2832-43. PubMed ID: 16988066
[TBL] [Abstract][Full Text] [Related]
14. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.
Liu E; Morimoto M; Kitajima S; Koike T; Yu Y; Shiiki H; Nagata M; Watanabe T; Fan J
J Am Soc Nephrol; 2007 Jul; 18(7):2094-104. PubMed ID: 17554151
[TBL] [Abstract][Full Text] [Related]
16. New insights into structural patterns encountered in glomerulosclerosis.
LeHir M; Kriz W
Curr Opin Nephrol Hypertens; 2007 May; 16(3):184-91. PubMed ID: 17420660
[TBL] [Abstract][Full Text] [Related]
17. Modulation of podocyte phenotype in collapsing glomerulopathies.
Barisoni L; Kopp JB
Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
[TBL] [Abstract][Full Text] [Related]
18. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
19. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
20. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis.
Lee HS; Lim SD
Clin Nephrol; 1995 Dec; 44(6):349-55. PubMed ID: 8719545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
